Ireland - English - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - hepatit a virus antigen, vi polysaccharide of salmonella typhi - suspension for injection - %v/v - bacterial and viral vaccines, combined

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi pasteur msd ltd - vi polysaccharide of salmonella typhi, hepatit a virus antigen - suspension for injection - bacterial and viral vaccines, combined

Canada - English - Health Canada

sanofi pasteur limited - salmonella typhi vi capsular polysaccharide vaccine; hepatitis a vaccine, inactivated - solution - 25mcg; 160unit - salmonella typhi vi capsular polysaccharide vaccine 25mcg; hepatitis a vaccine, inactivated 160unit - vaccines

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi pasteur - vi polysaccharide of salmonella typhi; hepatitis a virus - solution and suspension for suspension for injection in pre-filled syringe - 160/25 - bacterial and viral vaccines, combined; typhoid-hepatitis a

European Union - English - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - diphtheria toxoid, tetanus toxoid, inactivated bordetella pertussis, hepatitis b surface antigen (rdna), haemophilus influenzae type b polysaccharide - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; diphtheria - vaccines - quintanrix is indicated for primary immunisation of infants (during the first year of life) against diphtheria, tetanus, pertussis, hepatitis b and invasive disease caused by haemophilus influenzae type b and for booster immunisation of young children during the second year of life.the use of quintanrix should be determined on the basis of official recommendations.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - suspension for injection

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi pasteur msd ltd - suspension for injection

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - suspension for injection

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - hepatitis a virus (hm175 strain) inactivated; salmonella typhi (ty2 strain) vi capsular polysaccharide - suspension for injection

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - hepatitis a virus (gbm strain) inactivated; salmonella typhi (ty2 strain) vi capsular polysaccharide - suspension for injection